Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2020 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Amortizatization of Intangibles of $76000.0 for Q3 2024, down 62.75% year-over-year from $204000.0 in Q4 2023, and down 42.42% quarter-over-quarter from $132000.0 in Q2 2024.
Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2020 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $76000.0 for Q3 2024.
- In Q3 2024, Amortizatization of Intangibles fell 62.75% year-over-year to $76000.0; the TTM figure through Jun 2025 stood at $76000.0 (down 89.36% YoY), while the FY2024 annual figure was $396000.0, down 51.94% from the prior year.
- Amortizatization of Intangibles for Q3 2024 stood at $76000.0, down from $132000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $261984.0 in Q3 2021, with the low at $76000.0 in Q3 2024.
- The 5-year median for Amortizatization of Intangibles is $181483.0 (2022), against an average of $177219.1.
- The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles jumped 114.32% in 2022, then sank 62.75% in 2024.
- Corbus Pharmaceuticals Holdings' Amortizatization of Intangibles stood at $172415.0 in 2020, then plunged by 45.17% to $94535.0 in 2021, then soared by 114.32% to $202611.0 in 2022, then fell by 6.22% to $190000.0 in 2023, then slumped by 60.0% to $76000.0 in 2024.
- Business Quant data shows CRBP's Amortizatization of Intangibles at $76000.0 in Q3 2024, $132000.0 in Q2 2024, and $188000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 132,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Jun 30, 2023 | 228,877.00 |
| Jun 30, 2023 | 228,877.00 |
| Mar 31, 2023 | 201,123.00 |
| Mar 31, 2023 | 201,123.00 |
| Dec 31, 2022 | 202,611.00 |
| Dec 31, 2022 | 202,611.00 |
| Sep 30, 2022 | 182,403.00 |
| Sep 30, 2022 | 182,403.00 |
| Jun 30, 2022 | 180,563.00 |
| Jun 30, 2022 | 180,563.00 |